Thomson Reuters Foundation Recognizes Sheppard Mullin Pro Bono Team with 2020 TrustLaw Impact Award
The Thomson Reuters Foundation has awarded Sheppard, Mullin, Richter & Hampton LLP, Sisu Global Health and CFL Advocates with its 2020 TrustLaw Impact Award for their extraordinary work to improve access to blood during medical procedures and emergencies in Kenya. The Impact Award recognizes projects that demonstrate significant impact for a nonprofit organization or social enterprise, their community, and beyond.
Sisu Global Health is a medical device company that designs and commercializes medical devices with and for emerging markets. Its “Fighting Blood Shortages in Kenya” project aims to increase access to blood in all hospitals to reduce internal bleeding-related deaths through the use of HemafuseTM, an innovative medical device that filters and pumps blood from an internal hemorrhage into a blood bag, allowing it to be re-transfused to the same patient. The device can also be reused up to 25 times. Kenya is experiencing a chronic shortage of blood due to the lack of funds for screening tools and human resources to collect and store blood, and Hemafuse would provide a viable alternative to donor blood.
Sheppard Mullin partner Paul Garrity and associate Sam Cohen provided assistance on intellectual property matters, including drafting and filing trademark applications for both Sisu Global Health and its innovative Hemafuse product.
Watch the Impact story here.
Click here to view all the 2020 TrustLaw award winners.